FGFR1 and breast carcinoma: The promising anti-cancer effects of PD173074 have also been translated into a xenograft tumor model of breast cancer in BALB/c mice where 4T1 xenograft tumor growth was remarkably suppressed by this FGFR1/FGFR3 dual inhibitor.